News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

As Forest Laboratories, Inc. (FRX) CEO Plans Retirement, the Feds Issue a New Subpoena



5/29/2013 8:17:19 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Around the same time that Howard Solomon decided that he will soon retire as the long-standing ceo at Forest Laboratories, the drugmaker received a subpoena from the US Department of Justice concerning its Turdorza Pressair treatment for chronic obstructive pulmonary disease. Specifically, the subpoena arrived on May 6, and Solomon announced his pending departure on May 23. The timing may be coincidental and there was scant information released about the subpoena, other than that the drugmaker claims to be cooperating with the feds (see page 28). But the disclosure is an embarrassment for Forest Labs, given its recent history with marketing practices and the ensuing difficulties this caused Solomon two years ago.

Help employers find you! Check out all the jobs and post your resume.

Read at PharmaLive


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES